Works matching IS 10600280 AND DT 2010 AND VI 44 AND IP 3
2
- 2010
- Dunican KC;
- Adams NM;
- Desilets AR
- Journal Article
3
- 2010
- Forni A;
- Skehan N;
- Hartman CA;
- Yogaratnam D;
- Njoroge M;
- Schifferdecker C;
- Lilly CM
- Journal Article
4
- 2010
- Courter JD;
- Baker WL;
- Nowak KS;
- Smogowicz LA;
- Desjardins LL;
- Coleman CI;
- Girotto JE
- Journal Article
5
- 2010
- Hutchinson DJ;
- Liou Y;
- Best R;
- Zhao F
- Journal Article
6
- 2010
- Anderson SD;
- Shah NK;
- Yim J;
- Epstein BJ
- Journal Article
7
- Annals of Pharmacotherapy, 2010, v. 44, n. 3, p. 601
- Article
8
- Annals of Pharmacotherapy, 2010, v. 44, n. 3, p. 599, doi. 10.1345/aph.1BR10C
- Article
9
- Annals of Pharmacotherapy, 2010, v. 44, n. 3, p. 598, doi. 10.1345/aph.1M741
- Article
10
- Annals of Pharmacotherapy, 2010, v. 44, n. 3, p. 597
- Article
11
- Annals of Pharmacotherapy, 2010, v. 44, n. 3, p. 597, doi. 10.1345/aph.1M653
- Article
12
- Annals of Pharmacotherapy, 2010, v. 44, n. 3, p. 595, doi. 10.1345/aph.1L590a
- Article
13
- Annals of Pharmacotherapy, 2010, v. 44, n. 3, p. 594, doi. 10.1345/aph.1M629
- Article
14
- Annals of Pharmacotherapy, 2010, v. 44, n. 3, p. 590, doi. 10.1345/aph.1M568
- Article
15
- Annals of Pharmacotherapy, 2010, v. 44, n. 3, p. 587, doi. 10.1345/aph.1M585
- Article
16
- Annals of Pharmacotherapy, 2010, v. 44, n. 3, p. 582, doi. 10.1345/aph.1M480
- Article
17
- Annals of Pharmacotherapy, 2010, v. 44, n. 3, p. 577, doi. 10.1345/aph.1M642
- Article
18
- Annals of Pharmacotherapy, 2010, v. 44, n. 3, p. 572, doi. 10.1345/aph.1M519
- Article
19
- Annals of Pharmacotherapy, 2010, v. 44, n. 3, p. 565, doi. 10.1345/aph.1M498
- Article
20
- Annals of Pharmacotherapy, 2010, v. 44, n. 3, p. 557, doi. 10.1345/aph.1M339
- Article
21
- Annals of Pharmacotherapy, 2010, v. 44, n. 3, p. 546, doi. 10.1345/aph.1M377
- Article
22
- Annals of Pharmacotherapy, 2010, v. 44, n. 3, p. 538, doi. 10.1345/aph.1M210
- Article
23
- Annals of Pharmacotherapy, 2010, v. 44, n. 3, p. 524, doi. 10.1345/aph.1M548
- Article
24
- Annals of Pharmacotherapy, 2010, v. 44, n. 3, p. 515, doi. 10.1345/aph.1M468
- Article
25
- Annals of Pharmacotherapy, 2010, v. 44, n. 3, p. 507, doi. 10.1345/aph.1M624
- Article
26
- Annals of Pharmacotherapy, 2010, v. 44, n. 3, p. 489, doi. 10.1345/aph.1M332
- Article
27
- Annals of Pharmacotherapy, 2010, v. 44, n. 3, p. 479, doi. 10.1345/aph.1M567
- Article
28
- Annals of Pharmacotherapy, 2010, v. 44, n. 3, p. 471, doi. 10.1345/aph.1M344
- Article
29
- Annals of Pharmacotherapy, 2010, v. 44, n. 3, p. 466, doi. 10.1345/aph.1M341
- Article
30
- Annals of Pharmacotherapy, 2010, v. 44, n. 3, p. 462, doi. 10.1345/aph.1M647
- Article
31
- Annals of Pharmacotherapy, 2010, v. 44, n. 3, p. 456, doi. 10.1345/aph.1M631
- Article
32
- Annals of Pharmacotherapy, 2010, v. 44, n. 3, p. 447, doi. 10.1345/aph.1M527
- Article
33
- Annals of Pharmacotherapy, 2010, v. 44, n. 3, p. 439, doi. 10.1345/aph.1M602
- Article
34
- Annals of Pharmacotherapy, 2010, v. 44, n. 3, p. 432, doi. 10.1345/aph.1M576
- Article
35
- Annals of Pharmacotherapy, 2010, v. 44, n. 3, p. 424, doi. 10.1345/aph.1M386
- Article
36
- Annals of Pharmacotherapy, 2010, v. 44, n. 3, p. 415, doi. 10.1345/aph.1M522
- Article